Metro (TSX:MRU) is back in focus after third quarter results showed higher sales alongside a sharp decline in net income and earnings per share, compounded by a new asset impairment charge.
See our latest analysis for Metro.
At a share price of CA$89.71, Metro’s short term share price return has been soft, with the 30 day share price return down 3.19% and the year to date share price return down 9.39%. In contrast, the 3 year total shareholder return of 35.52% and 5 year total shareholder return of 52.73% point to longer term gains despite the recent earnings miss, impairment charge and the decision to hold the quarterly dividend steady.
If Metro’s recent results have you reassessing your watchlist, this could be a good moment to widen your scope and check out 3 top founder-led companies
Metro now trades at a discount to both analyst targets and an estimated fair value, even after the weak earnings and impairment charge. Is the market being too cautious, or simply pricing those risks correctly?
Most Popular Narrative: 10.7% Undervalued
Metro is trading at CA$89.71 against a widely followed fair value estimate of CA$100.45, which frames the current share price weakness in a different light.
Sustained improvements in supply chain automation and productivity at new and upgraded distribution centers are contributing to higher gross margins and are expected to continue supporting further net margin expansion as efficiencies mature and more products move through automated systems.
It is worth exploring how that automation story supports a higher value for Metro. The narrative focuses on steady revenue gains, firmer margins and a richer future earnings multiple. The full set of assumptions is where the picture comes together.
Result: Fair Value of CA$100.45 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to factor in risks such as rising competition and cost inflation, which could pressure Metro’s margins and challenge the current valuation story.
Find out about the key risks to this Metro narrative.
Next Steps
With Metro showing both pressure points and potential upside in this narrative, it makes sense to move quickly and test the story against the data yourself. To see how both sides of the argument compare in one place, take a closer look at the 3 key rewards and 1 important warning sign.
Looking for more ideas beyond Metro?
Do not stop at Metro. Use this moment to broaden your watchlist with fresh stock ideas that match your style and risk comfort.
- Target potential mispricings by reviewing companies highlighted in the 13 high quality undervalued stocks that combine solid fundamentals with room for the story to improve.
- Strengthen your income stream by focusing on resilient payers featured in the 4 dividend fortresses that aim to maintain meaningful yields.
- Protect your downside by concentrating on businesses in the 9 resilient stocks with low risk scores that score well on financial resilience and consistency.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com